SRIPLAW, Our passion, your protection

Your Passion, Our Protection

More than legal protection, we’re true partners to those shaping culture through creativity.

SRIPLAW - Blog Archives

Seeking Fame in Apple's Sea of Apps

Interesting piece in today's WSJ entitled "Seeking Fame in Apple's Sea of Apps." The article notes that Apple gets 30% of any third-party app sales, and that as of today customers had downloaded more than 1.5 billion free and paid apps.
Read More
READ MORE

Justia tags monitor apps cases in federal court

Legal filings aggregator Justia tags cases filed in federal court with relevant keywords including "iTunes."  This makes finding new filings related to whatever keyword interests you quite simple.
Read More
READ MORE

Apps Law Blog is Launched!

Welcome to our new blog, published by lawyers Kevin Houchin and Joel Rothman.  Houchin and Rothman are better known as the attorneys who filed the now infamous iFart v.
Read More
READ MORE

Vitamin D at 5,000 IU: Too high, or just too soon?

GUEST BLOG by David A. Mark The Institute of Medicine is currently reviewing the Dietary Reference Intake value for vitamin D that last changed in 1997.
Read More
READ MORE

Florida a speedy forum of choice in IP cases.

A recent study by LegalMetrics, a litigation analysis firm, named the Southern and Middle Districts of Florida among the top five districts for speed to resolution in patent infringement cases.  
Read More
READ MORE

Who answers the supplement hotline for NFL players?

Calvin Pace of the New York Jets will be sitting out the first four games of the 2009 season because he violated the National Football League's policy on doping.
Read More
READ MORE

Product quality: the never-ending frontier of GMP

Following up on a post from June 30, the question of consumer confidence in nutritional supplements arises again. The Times-Herald reports that many supplements have quality problems. 
Read More
READ MORE

Who pays for product safety and quality?

Anne Hart has lots of questions about the quality and safety of nutritional supplements, 19 questions to be exact. They revolve around product integrity, contamination, mislabeling (think sibutramine), FDA oversight and so on. 
Read More
READ MORE

For Zicam's maker, troubles do not end with recall

Manufacturers beware. Your regulatory problems may not be over when you pull a product from the store shelves. Matrixx Initiatives Inc. recalled its Zicam products on June 16 and three days later the Securities & Exchange Commission sent a letter of inquiry.
Read More
READ MORE

NutriSupLaw Blog Editor and Publisher Joins Arnstein & Lehr!

The Nutritional and Dietary Supplement Law Blog is pleased as punch to announce that Joel B. Rothman, your faithful editor and publisher, has joined the West Palm Beach office of Arnstein & Lehr LLP as a partner.
Read More
READ MORE
1 21 22 23 24 25 44

Get in Touch or Submit Your Case for Review

From general questions to potential IP misuse, choose the option that best fits your case.

Our team will review your submission and get back to you as soon as possible.